
The following content is not intended as investment advice. The author does not hold any positions in the stocks mentioned herein.
Andrew Left’s Bold Short Bet Against Palantir
In a striking move that has captured market attention, Andrew Left of Citron Research has initiated a short position on Palantir Technologies. This decision has been characterized by analysts as a “widow-maker”trade, fraught with potential risks reminiscent of a classic Titanic scenario. Yet, as the saying goes, “Fortune favors the bold, ”and Left’s position may either lead him to victory or downfall in this high-stakes financial environment.
Citron Research’s Andrew Left told Fox Business he’s short Palantir $PLTR and added to his position after earnings, calling the trade “obvious.” He said he likes the company and CEO Alex Karp, but thinks the stock is overpriced.
— Wall St Engine (@wallstengine) August 13, 2025
Understanding Palantir’s Business Model
During an appearance on Fox Business, Andrew Left explicitly stated his short on Palantir, emphasizing that he escalated his position following the company’s latest earnings report, deeming it to be “obvious”to take this position. Palantir operates with two specialized platforms: Gotham, tailored for governmental data analytics, and Foundry, which supports enterprises in data aggregation and analysis. The company has also introduced its custom Artificial Intelligence Platform (AIP), which facilitates the integration of various large language models (LLMs) and generative AI into business operations.
Recent Earnings Results and Analyst Reactions
Palantir recently announced an impressive quarterly earnings report, leading analysts at Morgan Stanley to express their astonishment:
“Wow… is our reaction to Q2 results with nearly every headline metric and KPI accelerating versus Q1 which itself was a very strong quarter.”
The firm exceeded expectations across the board, achieving its first billion-dollar quarter with revenues of $1.004 billion—significantly surpassing the consensus estimate of $939.71 million. This success was supported by 157 contract closures of at least $1 million, contributing to a remarkable total contract value (TCV) of $2.27 billion, marking an impressive 140% year-over-year growth.
Projected Growth and Financial Outlook
The standout performer was Palantir’s commercial segment, which is projected to generate over $1.302 billion in FY 2025, reflecting an estimated year-over-year growth rate of at least 85%.CEO Alex Karp is ambitious, aiming for a tenfold increase in this run-rate over the next five years, which translates to a compound annual growth rate (CAGR) of approximately 58%, based on UBS’s evaluations.
Furthermore, the company’s guidance was robust, forecasting revenues between $1.083 billion and $1.087 billion for the third quarter and elevating its full-year revenue forecast to $4.142 – $4.152 billion, alongside anticipated free cash flow between $1.8 billion and $2.0 billion.
Karp also cited three primary growth drivers during the earnings call: the rising demand for custom AI applications, increased investment in data infrastructure, and the modernization of defense technology.
The Valuation Dilemma
Despite these promising earnings and guidance, Palantir’s exorbitant valuation has become a significant point of contention. With a trailing price-to-earnings (P/E) ratio of 614.57 and a forward P/E of 294.12, the company’s valuation metrics stand out alarmingly against industry peers; for instance, SAP maintains a trailing P/E ratio of approximately 45.20.
Andrew Left’s Short Selling Track Record
Andrew Left is a seasoned short-seller with a track record that includes notable victories. Previously, Citron Research took a stance against Nikola Corporation, branding it as an “intricate fraud, ” which resulted in a substantial drop in share price and the resignation of its CEO Trevor Milton. The firm has also had a significant impact on Jumia Technologies’ stock, although it later altered its bearish position as the company shifted its strategy.
The Market’s Rationality Question
The prevailing adage suggests that “the market can remain irrational longer than investors can remain solvent.”While it’s widely acknowledged that Palantir’s stock appears overvalued, the critical question remains: Can Andrew Left sustain his short position in the face of possible momentum-driven surges? Will he find himself covering his short amid market fluctuations, reminiscent of the GameStop frenzy, or will he emerge vindicated, similar to his success with Nikola?
For further insights, you can view the full discussion here.
Leave a Reply